Amy Schink

Title: Amy Schink: Innovator in Pharmaceutical Formulations

Introduction

Amy Schink is a notable inventor based in San Diego, California. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of mimetics for UEA-1. Her innovative work has led to the creation of a patent that addresses important therapeutic and diagnostic applications.

Latest Patents

Amy Schink holds a patent for "Pharmaceutical formulations and ligands for use therein; mimetics for UEA-1." This patent includes UEA-1 mimetics, pharmaceutical formulations comprising them, and their uses as targeting agents for therapeutic and diagnostic purposes. This invention showcases her expertise in creating effective solutions in the pharmaceutical industry.

Career Highlights

Throughout her career, Amy has demonstrated a strong commitment to advancing medical science. She is currently associated with Sarlan, Ltd., where she continues to innovate and contribute to the development of new pharmaceutical products. Her work is characterized by a focus on improving patient outcomes through targeted therapies.

Collaborations

Amy has collaborated with esteemed colleagues, including Richard Allen Houghten and Clemencia Pinilla. These partnerships have enriched her research and expanded the impact of her inventions in the pharmaceutical field.

Conclusion

Amy Schink is a pioneering inventor whose work in pharmaceutical formulations has the potential to transform therapeutic and diagnostic practices. Her contributions are invaluable to the medical community and highlight the importance of innovation in healthcare.